Palisade Bio Appoints New CEO, Board Changes
Ticker: PALI · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment, board-of-directors
TL;DR
New CEO David Mazzo in, old CEO Robert Diamond out at Palisade Bio as of July 2nd.
AI Summary
Palisade Bio, Inc. announced on July 2, 2025, a change in its board of directors. Specifically, Dr. David J. Mazzo has been appointed as the new Chief Executive Officer and a member of the Board of Directors, effective immediately. Concurrently, Dr. Robert L. Diamond has resigned from his positions as CEO and Board member.
Why It Matters
This leadership change at the executive and board level could signal a new strategic direction for Palisade Bio, potentially impacting its drug development pipeline and future performance.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty regarding strategy and execution, impacting the company's operational stability and future prospects.
Key Players & Entities
- Palisade Bio, Inc. (company) — Registrant
- David J. Mazzo (person) — Appointed CEO and Board Member
- Robert L. Diamond (person) — Resigned CEO and Board Member
- July 2, 2025 (date) — Effective date of changes
FAQ
Who has been appointed as the new CEO of Palisade Bio, Inc.?
Dr. David J. Mazzo has been appointed as the new Chief Executive Officer of Palisade Bio, Inc.
When did the leadership changes at Palisade Bio, Inc. become effective?
The leadership changes became effective on July 2, 2025.
Who resigned from their positions as CEO and Board member at Palisade Bio, Inc.?
Dr. Robert L. Diamond resigned from his positions as CEO and Board member.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 2, 2025.
What is the company's Standard Industrial Classification code?
The company's Standard Industrial Classification code is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 by David J. Mazzo regarding PALISADE BIO, INC. (PALI).